Similar content being viewed by others Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are structurally modified analogs of endogenous GLP-1, engineered to resist enzymatic degradation while retaining potent agonism at the GLP-1 receptor (GLP-1R) 1
Both medications carry warnings, so a medical evaluation is essential before starting
Both creatine and acetyl-L-carnitine support cellular energy function
Some other GLP-1 medicines available today include semaglutide (sold as Wegovy, Ozempic, and Rybelsus), tirzepatide (Mounjaro a medicine that acts on both GIP and GLP1 receptors, sometimes called a twincretin), and liraglutide 2 , 3
In addition to their impressive impact on weight, GLP-1 agonists also provide valuable health advantages, including better blood sugar control for those living with type 2 diabetes and a lowered risk of cardiovascular disease